Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.

Cantelmo AR, Conradi LC, Brajic A, Goveia J, Kalucka J, Pircher A, Chaturvedi P, Hol J, Thienpont B, Teuwen LA, Schoors S, Boeckx B, Vriens J, Kuchnio A, Veys K, Cruys B, Finotto L, Treps L, Stav-Noraas TE, Bifari F, Stapor P, Decimo I, Kampen K, De Bock K, Haraldsen G, Schoonjans L, Rabelink T, Eelen G, Ghesquière B, Rehman J, Lambrechts D, Malik AB, Dewerchin M, Carmeliet P

Open source

DOI
10.1016/j.ccell.2016.10.006
Published
2016 Dec 12
Container
Cancer cell
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ccell.2016.10.006,
  title = {Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.},
  author = {Cantelmo AR and Conradi LC and Brajic A and Goveia J and Kalucka J and Pircher A and Chaturvedi P and Hol J and Thienpont B and Teuwen LA and Schoors S and Boeckx B and Vriens J and Kuchnio A and Veys K and Cruys B and Finotto L and Treps L and Stav-Noraas TE and Bifari F and Stapor P and Decimo I and Kampen K and De Bock K and Haraldsen G and Schoonjans L and Rabelink T and Eelen G and Ghesquière B and Rehman J and Lambrechts D and Malik AB and Dewerchin M and Carmeliet P},
  year = {2016},
  journal = {Cancer cell},
  doi = {10.1016/j.ccell.2016.10.006},
  url = {https://doi.org/10.1016/j.ccell.2016.10.006}
}

RIS

TY  - JOUR
TI  - Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.
AU  - Cantelmo AR
AU  - Conradi LC
AU  - Brajic A
AU  - Goveia J
AU  - Kalucka J
AU  - Pircher A
AU  - Chaturvedi P
AU  - Hol J
AU  - Thienpont B
AU  - Teuwen LA
AU  - Schoors S
AU  - Boeckx B
AU  - Vriens J
AU  - Kuchnio A
AU  - Veys K
AU  - Cruys B
AU  - Finotto L
AU  - Treps L
AU  - Stav-Noraas TE
AU  - Bifari F
AU  - Stapor P
AU  - Decimo I
AU  - Kampen K
AU  - De Bock K
AU  - Haraldsen G
AU  - Schoonjans L
AU  - Rabelink T
AU  - Eelen G
AU  - Ghesquière B
AU  - Rehman J
AU  - Lambrechts D
AU  - Malik AB
AU  - Dewerchin M
AU  - Carmeliet P
PY  - 2016
JO  - Cancer cell
DO  - 10.1016/j.ccell.2016.10.006
UR  - https://doi.org/10.1016/j.ccell.2016.10.006
ER  - 

APA

AR, C., LC, C., A, B., J, G., J, K., A, P., P, C., J, H., B, T., LA, T., S, S., B, B., J, V., A, K., K, V., B, C., L, F., L, T., TE, S., F, B., P, S., I, D., K, K., K, D. B., G, H., L, S., T, R., G, E., B, G., J, R., D, L., AB, M., M, D., & P, C. (2016). Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy.. Cancer cell. https://doi.org/10.1016/j.ccell.2016.10.006

Source records